Management of Immunosuppression in Kidney Transplant Recipients Who Develop Malignancy

The risk of cancer increases after transplantation. However, the consensus on immunosuppression (IS) adjustment after diagnosis of malignancy is lacking. Our study aims to assess the impact of IS adjustment on mortality of post-kidney transplant patients and allograft outcomes. We retrospectively re...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Danwen, Thamcharoen, Natanong, Cardarelli, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947374/
https://www.ncbi.nlm.nih.gov/pubmed/31835895
http://dx.doi.org/10.3390/jcm8122189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947374/
https://www.ncbi.nlm.nih.gov/pubmed/31835895
http://dx.doi.org/10.3390/jcm8122189

Ejemplares similares